Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors
Year: 2008
Type: article
Source: Cancer Research
Authors: Merchant Mark, Kun Zhang, Yanli Su, María del Socorro Camarillo Romero, Sharianne G. Louie, Christophe Severin, Nerissa Mendoza, Zhong Zheng, T F Dekoning, Dafna Kaufman, George Vande Woude, Jiping Zha, Robert L. Yauch, Ellen Filvaroff
Institutions: Van Andel Institute, Genentech
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2946994377